Private Equity Asset Management
Planet Pharmacies (“Planet”) is a UAE based company focused on the acquisition, operation and management of retail pharmacies in any region and is one of the leading healthcare products retailers & distributors in this domain.
The Company acquired the pharmacy and distribution business of Julphar. Post-acquisition, the Company had sold off and closed some non-performing branches and initiated an acquisitive growth plan.
Planet acquired a large retail pharmacies’ chain in KSA with 51 pharmacies in addition to other pharmacies in Oman.
After optimization of the store portfolio and ongoing expansion, the Company currently has 162 retail pharmacies, spread across UAE, Oman & KSA.
Our Approach to Add Value
Helped in finalizing the acquisitions made which lead to the enhancement of value proposition from new manufacturing initiatives.
Internal audit reviews and improvement in internal controls.
Improvement in reporting and financial performance dashboards.
New acquisitions initiatives/targets in UAE and KSA.
Optimizing the company’s capital structure to maximize shareholders value.
Additions to the management team and hiring and induction of the Group GM.
Overseeing the growth in new agencies business and development of the warehouses in UAE, KSA & Oman.
Promoting management by objectives and long-term incentive scheme for alignment of interests.
Consolidating the business was one of the key challenges across the various pharmacies in different countries.
Optimal utilization of excess cash.
Expansion by acquisition and the introduction of new investment opportunities.
Planet has effectively consolidated its business operations and has now a sustainable revenue stream.
Planet has grown its retail pharmacies network across three countries, closing non-performing ones and optimizing the number of operating pharmacies.
Steady growth in revenues with improving net income after the reorganization of the Company. In 3 years only (from 2011 till 2014):
Revenues grew by 1.6x
From a negative EBITDA of USD5.8mn to a positive EBITDA of USD13.3mn
From a Net Loss of USD6.0mn to a Net Profit of USD11.1mn